Found 9 matching trials
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
PHASE2This experiment will test the safety and effectiveness of a treatment for m...
Location
National Cancer Institute (NCI)
Radiation, Chemotherapy, Vaccine and Anti-MART-1 and Anti-gp100 Cells for Patients With Metastatic Melanoma
PHASE2Background:
* Melanoma antigen recognized by T-cells (MART-1) and gp100 ar...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
PHASE2RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients
PHASE2Background:
* Melanoma antigen recognized by T cells (MART-1) is a gene th...
Location
National Cancer Institute (NCI), 9000 Rockville Pike
Peptide Vaccination for Patients at High Risk for Recurrent Melanoma
PHASE2This study will examine the effectiveness and side effects of an experiment...
Location
National Cancer Institute (NCI)
Dendritic Cell Vaccination During Lymphoid Reconstruction
PHASE1This is a randomized, controlled, multicenter, dose-escalation study of flu...
Location
H. Lee Moffitt Cancer Center and Research Institute
Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
PHASE1RATIONALE: Vaccines made from peptides may help the body build an effective...
Location
UPMC Cancer Centers
Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured
PHASE1RATIONALE: Vaccines made from gene-modified tumor cells may help the body b...
Location
H. Lee Moffitt Cancer Center and Research Institute
Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558
PHASE1This is a pilot phase 1, open-label, single center, multi-dose, dose-escala...
Location
H. Lee Moffitt Cancer Center and Research Institute